NeuPath Health (NPTH) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
26 Mar, 2026Investment highlights
Operates regulated healthcare facilities with specialized personnel and equipment, supporting a strong organic growth profile and positive cash flows.
Addresses a large and growing market with significant patient backlog and untapped inorganic growth opportunities.
Successful turnaround with expanding margins and ability to invest in new growth initiatives.
Service offerings
Provides a wide range of pain management services, including injections, infusions, physical therapy, and third-party services such as acupuncture and massage.
Geographic reach and expansion
Operates one of the largest chronic pain facility networks in Canada, covering about 67% of Ontario and 38% of Alberta's populations.
Plans to expand in existing and new high-growth regions across Canada.
Latest events from NeuPath Health
- Q2 2026 revenue hit $23.2M with record patient visits and ongoing share buybacks.NPTH
Q2 2026 - Strong revenue growth and expanding physician capacity drive value in a fragmented pain care market.NPTH
2026 Bloom Burton & Co. Healthcare Investor Conference - Q2 2024 revenue up 11% year-over-year, gross margin at 20.0%, net debt down 37%.NPTH
Q2 2024 - Q3 2024 revenue and adjusted EBITDA both rose 9% year-over-year, with improved capacity and lower net debt.NPTH
Q3 2024 - Revenue and adjusted EBITDA rose year-over-year, with new growth investments and clinical milestones.NPTH
Q4 2024 - Record revenue and margin growth in Q1 2025, with new financing and leadership for future expansion.NPTH
Q1 2025 - Record revenue and EBITDA growth driven by clinic optimization and new procedure uptake.NPTH
Q2 2025 - Q1 2026 delivered 11% revenue and 15% EBITDA growth, with expansion and new leadership.NPTH
Q1 2026 - Record 2025 revenue and EBITDA growth, with strong outlook for further expansion and margin gains.NPTH
Q4 2025